Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Opis bibliograficzny
Główni autorzy:	Flossmann, O, Jones, R, Jayne, DR, Luqmani, R
Format:	Journal article
Język:	English
Wydane:	2006

Podobne zapisy

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
od: Mukhtyar, C, i wsp.
Wydane: (2006)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
od: Mukhtyar, C, i wsp.
Wydane: (2008)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
od: Saket Jha, i wsp.
Wydane: (2019-01-01)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
od: Zhi-Ying Li, i wsp.
Wydane: (2020-08-01)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
od: Moog P, i wsp.
Wydane: (2015-11-01)

A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
od: Mahmoud M. Mohamed, i wsp.
Wydane: (2023-07-01)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
od: Walsh, M, i wsp.
Wydane: (2011)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
od: Robson, J, i wsp.
Wydane: (2013)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
od: Morishita, K, i wsp.
Wydane: (2017)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
od: Guerry, M, i wsp.
Wydane: (2012)

Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies
od: E. N. Vorkel, i wsp.
Wydane: (2024-08-01)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
od: E. N. Vorkel, i wsp.
Wydane: (2024-12-01)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
od: Megan M. Sullivan, i wsp.
Wydane: (2024-01-01)

Health-related quality of life after Rituximab treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis
od: Iva Parvova, i wsp.
Wydane: (2024-11-01)

Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab
od: Carmen Martín Varas, i wsp.
Wydane: (2017-09-01)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
od: De Groot, K, i wsp.
Wydane: (2005)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
od: Deep Shikha, i wsp.
Wydane: (2015-01-01)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
od: Mukhtyar, C, i wsp.
Wydane: (2008)

Rituximab in relapsed/refractory antineutrophil cytoplasmic antibody associated vasculitis: A single-center prospective observational study
od: Ekbote Gayatri, i wsp.
Wydane: (2019-01-01)

Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis
od: Valérie Bénard, i wsp.
Wydane: (2021-07-01)

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
od: Katarzyna Wawrzycka-Adamczyk, i wsp.
Wydane: (2024-08-01)

Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
od: Sunil Kapur, i wsp.
Wydane: (2021-01-01)

Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis
od: Durga Prasanna Misra, i wsp.
Wydane: (2019-01-01)

Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis
od: Weiwei Hao, i wsp.
Wydane: (2024-07-01)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
od: Noah Huizenga, i wsp.
Wydane: (2020-04-01)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
od: T V Beketova
Wydane: (2018-05-01)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
od: Weiran Li, i wsp.
Wydane: (2021-03-01)

Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
od: Yoon Kook Kim, MD, i wsp.
Wydane: (2021-02-01)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
od: Talks, S, i wsp.
Wydane: (1994)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
od: Jamie R. Felzer, i wsp.
Wydane: (2022-01-01)

Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
od: O. N. Egorova, i wsp.
Wydane: (2024-10-01)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.
od: Sourabh Chand, i wsp.
Wydane: (2013-01-01)

Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
od: Ulrich Specks, i wsp.
Wydane: (2025-01-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in a patient with diffuse scleroderma
od: B N Shiva Prasad, i wsp.
Wydane: (2021-01-01)

The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis
od: Kunal Chandwar, i wsp.
Wydane: (2022-01-01)

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
od: Zdenka Hruskova, i wsp.
Wydane: (2020-02-01)

Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China
od: Xiang-Yu Han, i wsp.
Wydane: (2024-05-01)

Treatment of severe perinuclear antineutrophil cytoplasmic antibody–associated vasculitis with efgartigimod
od: Afsoon Ghafari-Saravi, BS, i wsp.
Wydane: (2024-05-01)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
od: Robson, J, i wsp.
Wydane: (2017)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
od: de Groot, K, i wsp.
Wydane: (2009)